Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
December 14 2024 - 4:54PM
Ted Kellner, as the nominating stockholder and a nominee, together
with his other nominees, Todd Deutsch, Robert L. Chioini and Paul
W. Sweeney (collectively, the “Kellner Group,” “we” or “us” and, as
nominees, the “Kellner Group Nominees”), issues this urgent
statement in response to baseless, deceptive rumors and in
connection with their efforts to bring accountability to the
entrenched, incumbent Board of Directors of AIM Immunotech Inc.
(NYSE American: AIM).
Kellner Group has
Never Shorted AIM Stock
Equels and Incumbent Board are the
Problem. We are the Solution.
Ted Kellner and Todd Deutsch are long-term, significant AIM
stockholders. Neither has traded AIM stock at all recently. The
Kellner Group is collectively the largest AIM stockholder and our
interest is squarely aligned with maximizing value for all
stockholders. We are committed to delivering the urgent change that
AIM desperately needs. We have no motive other than to salvage AIM
and create value for all stockholders
It has come to our attention that lies are being spread that we
are involved in short selling AIM stock. These claims are
absolutely false.
Nobody in the Kellner Group has ever engaged in shorting
AIM stock. If Equels, other AIM representatives and anybody else is
claiming otherwise, they are lying. It is
absolutely false that there was any shred of evidence to the
contrary in past legal proceedings.
The only truth is that the incumbent Board desperately and
unsuccessfully tried to fabricate yet another lie about Ted Kellner
in the Delaware court proceedings. Mr. Kellner jotted a note about
concerns with potential short selling—concerns that are entirely
justified and shared by any legitimate stockholder who cares about
AIM’s future! These concerns were not a sign of any involvement in
short selling; rather, they were a clear reflection of the risks
stockholders face when the Board utterly fails to serve
shareholders and prioritizes their own self-interests at the
expense of the company’s future. It is yet another
example of the deceitful tactics employed by Equels and the other
incumbent AIM directors, whose entire campaign against us has been
built on gross deception. They have completely failed stockholders,
and this is the only strategy they have left—lying and misdirecting
attention from their own incompetence.
The Real Problem Lies with the Incumbent
Board.
The incumbent Board, led by Mr. Equels, has failed AIM and its
stockholders at every turn. They have allowed AIM’s stock price to
fall and failed to attract meaningful interest from institutional
investors or the broader market. The short sellers are not afraid
of getting squeezed because the incumbent Board has no credibility
and regardless of what AIM announces, they know the Board won’t
deliver results and are unable to attract investor interest. This
is a crisis that will not fix itself, and AIM cannot afford to
continue down this destructive path.
The solution is clear: the Kellner Group offers the leadership,
experience, and vision necessary to restore AIM to its rightful
potential. Electing the Kellner Group will bring the decisive
action needed to drive performance and create real value for
stockholders that will lead the shorts and manipulators will run
for the hills.
The stock only goes one way with Equels and the other
incumbent AIM directors in control – down!
Vote FOR all four Kellner Group nominees today to change
this and AIM’s future!
We are the solution to AIM’s problems!
We urge all AIM stockholders that care about its future
to carefully read our open letter to stockholders issued as a press
release yesterday, available at
https://okapivote.com/aim.
THE KELLNER GROUP URGES ALL STOCKHOLDERS
TO VOTE ON
THE GOLD PROXY
CARD TODAY TO ELECT TED
D. KELLNER, TODD DEUTSCH, ROBERT L. CHIOINI AND PAUL
SWEENEY
If you have any questions, require assistance in voting
your GOLD proxy card, or need additional
copies of the Kellner Group’s proxy materials, please contact Okapi
Partners at the phone numbers or email address listed below. Please
also visit https://okapivote.com/AIM/ for additional
information.
Contact:
Okapi Partners LLC1212 Avenue of the Americas,
17th Floor,New York, New York 10036Stockholders may
call toll-free: (844) 343-2621Banks and
brokers call: (212) 297-0720Email:
info@okapipartners.com
Important Information and Participants in the
Solicitation
The Kellner Group has filed a definitive proxy statement and
associated GOLD proxy card with the
Securities and Exchange Commission (“SEC”) to be used to solicit
votes for the election of its slate of highly-qualified director
nominees at the upcoming annual meeting of stockholders of AIM.
Details regarding the Kellner Group nominees are included in its
proxy statement.
THE KELLNER GROUP STRONGLY ADVISES ALL STOCKHOLDERS OF AIM TO
READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME
AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
Information regarding the identity of participants in the
Kellner Group’s solicitation, and their direct or indirect
interests, by security holdings or otherwise, is set forth in the
Kellner Group’s proxy statement and additional proxy materials
filed with the SEC. Stockholders can obtain a copy of the proxy
statement, and any amendments or supplements thereto and other
documents filed by the Kellner Group with the SEC for no charge at
the SEC’s website at www.sec.gov. Copies will also be available at
no charge at the following website: https://www.okapivote.com/AIM.
Investors can also contact Okapi Partners LLC at the telephone
number or email address set for the above.
AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Nov 2024 to Dec 2024
AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Dec 2023 to Dec 2024